CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 111 enrolled
Drug / intervention
Bupivacaine +8 moredrug
Likely dose
8 MHz. Chiba needle, 22 G / 4 inchesfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02292082
NCT02292082Phase 4Completed
CompareCT.gov

The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)

Hospital for Special Surgery, New York·interventional·Posted Nov 17, 2014·Updated Jan 11, 2019

In Brief

A Phase 4 clinical trial evaluating Bupivacaine, Morphine, and 7 other interventions for Osteoarthritis. Completed, enrolled 111 participants across 1 site.

Detailed Summary

Total knee replacement is associated with severe post-operative pain. The purpose of this study is to compare two methods of treatment for pain control following Total Knee Replacement with an accelerated physical therapy protocol to aid the achievement of rehab milestones.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedNov 17, 2014
Enrollment StartNov 1, 2014
Primary CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.6 years ago

Interventions

Bupivacainedrug

Morphinedrug

Methylprednisolonedrug

Cefazolindrug

Normal salinedrug

Midazolamdrug

Propofoldrug

Dexamethasonedrug

8 MHz. Chiba needle, 22 G / 4 inchesdevice